Open Compound-Gene Network in Metscape
Compound Name Pubchem ID Kegg ID
Pentetic acid 3053; --
fentanyl 3345; --
GV-Eleven 3468; --
iohexol 3730; --
iomeprol 3731; --
iotrolan 3738; --
2-[(2,6-dimethylphenyl)amino]-n,n-diethyl-2-oxoethanaminium 3924; --
meglumine 4049; 8567; --
6-.alpha.-Methylprednisolone 4159; --
3-Oxoestr-4-en-17-yl decanoate 4432; --
Morphinan-6-one, 4,5.alpha.-epoxy-14-hydroxy-3-methoxy-17-methyl- 4635; --
EINECS 220-831-4 5523; --
ST013877 5544; --
(5|A,9|A)-14-hydroxy-3-methoxy-17-methyl-4,5-epoxymorphinan-6-one 6445; --
methylprednisolone 6741; --
Crystal violet 11057; --
FENTANYL CITRATE 13810; --
Durapatite 14781; --
Calcium DIPA 17320; --
tramazoline hydrochloride 19472; 443950; --
GADOLINIUM 23982; --
Hyaluronan 24759; --
triamcinolone 31307; --
Magnevist 55466; --
tramadol hydrochloride 63013; --
AC1L1Y7J 63015; --
Methylprednisolone aceponate 63019; --
Bupivacaine hydrochloride 64737; --
iopamidol 65492; --
Ropivacaine 71273; 175805; C07532;
Polyglactin 71391; --
Nandrolone dodecanoate 94371; --
calcium hydrogenphosphate dihydrate 104805; --
AC1L3GO5 115181; --
Ethylene-d4 123083; --
SureCN13575862 134645; --
Ethylene-d1 137676; --
Ethylene-d3 137677; --
Betamethasone 17,21-dipropionate 146364; --
Gadopentetic acid 157429; 56841013; --
Nandrolone cyclotate 164526; --
Gadolinium(3+) 168050; --
Ropivacaine hydrochloride 175804; --
AC1L5352 197247; --
Estr-4-en-3-one, 17.beta.-hydroxy- 220503; --
AC1L9P2J 450643; --
AC1L9P2Q 450650; --
2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol 451049; --
AC1L9PD5 451053; --
AC1L9PIU 451270; --
HYALURONIC ACID 453617; 453618; 3084050; 24728612; --
(-)-Tramadol 667511; --
AC1LJ6SD 969500; --
AC1LT4C5 1550969; --
SBB058527 2724052; --
AC1MBZSR 2733846; --
AC1MBOMN 2754096; --
Benzoic acid, triiodo- 3015392; --
AC1NUTLQ 5460714; --
SureCN618773 5464087; --
Spectrum_001873 5702085; --
AC1NWAQV 5702125; --
AC1NX6NU 5745355; --
Disodium dichloride 6398980; --
AC1O5DGV 6432032; --
Zinc-DTPA 6441444; --
17|A-Nortestosterone 6451993; --
CAS-6284-40-8 6560359; --
CAS-66108-95-0 6604427; --
(NaCl)2 6914545; --
Dotarem 6918037; --
AC1OFCLX 7048705; --
AC1OFCN6 7048722; --
AC1OEUMV 7087517; --
2-hydroxypropanoic acid 9812756; 10154003; 10197628; 11686901; --
SureCN57495 9813907; --
(2S,3R,4S,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol 9877098; --
(6S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one 9892717; --
SureCN1994014 9904960; --
Tramadol-d6 Hydrochloride 9971980; --
(8R,9S,10R,13R,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one 10016199; --
(9S,14S,17R)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one 10061922; --
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide 10247155; --
(8S,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one 10378880; --
(2S)-2-deuterio-2-hydroxypropanoic acid 11251964; --
2-[di(ethyl)amino]-N-(2,6-dimethylphenyl)acetamide 11436229; --
SureCN46222 11518351; --
LIDOCAINE AND TETRACAINE 11720242; --
ZINC08615398 11865439; --
ZINC05529987 11865440; --
ZINC03831184 11865441; --
ZINC03831185 11865442; --
ZINC03881944 11869640; --
ZINC03881945 11869641; --
ZINC03881946 11869642; --
ZINC04062829 11875291; --
(8R,9S,10S,13S,14S,17R)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one 11875292; --
(8S,9R,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one 11888113; --
ZINC04292883 11888114; --
ZINC04292884 11888115; --
CAS-83-43-2 11972591; --
LS-188030 13879490; --
AC1NWAOL 16394598; --
SureCN600040 21140858; --
SureCN4448 22845741; --
DNC005083 23662696; --
HYALURONIC ACID SODIUM SALT 23663392; --
Solu-Medrol 23680530; --
Etamucine 24847767; --
LS-187877 24847994; --
LS-187878 24847995; --
LS-187879 24847996; --
LS-187880 24847997; --
LS-187881 24847998; --
LS-187882 24847999; --
ELLIOTTS B SOLUTION 24848000; --
LS-187884 24848001; --
LS-187885 24848002; --
LS-187886 24848003; --
LS-187887 24848004; --
LS-187888 24848005; --
ISOLYTE E IN PLASTIC CONTAINER 24848006; --
PLASMA-LYTE R IN PLASTIC CONTAINER 24848007; --
CARDIOPLEGIC IN PLASTIC CONTAINER 24848008; --
LS-187892 24848009; --
RINGER'S IN PLASTIC CONTAINER 24848010; --
LS-187894 24848011; --
LS-187897 24848014; --
LS-188005 24848100; --
LS-188006 24848101; --
LS-188007 24848102; --
NORMOCARB HF 35 24848103; --
TIS-U-SOL IN PLASTIC CONTAINER 24848104; --
LS-188045 24848129; --
LS-188057 24848140; --
LS-188058 24848141; --
LS-188060 24848143; --
LS-188061 24848144; --
LS-188063 24848146; --
LS-188064 24848147; --
LS-188066 24848149; --
LS-188067 24848150; --
LS-188068 24848151; --
LS-188069 24848152; --
LS-188080 24848163; --
[beta-N-acetyl-D-glucosaminyl(1->4)beta-D-glucuronosyl(1->3)](n) 25202841; --
UNII-RH248G8V27 44144427; --
SureCN12101449 44264743; --
CHEMBL278063 44270140; --
AKOS015962210 45357583; --
AKOS015962268 45357602; --
AKOS015892745 45358069; --
HMDB02061 53477741; --
7081-EP2270008A1 53627537; --
tenoxicam 54677971; --
(1S,2R,10S,11S,13R,14S,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one 71299643; --
UNII-L0ND3981AG 71300721; --
AGN-PC-0D91PM 72641011; --
Lactate 612; C01432;
Bupivacaine 2474; C07529;
Lidocaine 3676; C07073;
Sodium chloride 5234; C13563;
D-Sorbitol 5780; C00794;
Nandrolone decanoate 9677; C08154;
Nandrolone 9904; C07254;
Monobasic calcium phosphate 24454; C13556;
Tricalcium phosphate 24456; C08136;
Tramadol 33741; C07153;
(R)-Lactate 61503; C00256;
(S)-Lactate 107689; C00186;
Fibrin 439199; C00290;
Oxycodone 5284603; C08018;
L-Iditol 5460044; C01507;
omega-Hydroxy fatty acid;Glycolate 757; C03547; C00160;
Ethylene;Polyethylene 6325; C06547; C19503;